NAC for Skin Picking and Hair Pulling: The Evidence
Photo by Anastasia Zhenina
NAC for skin picking and hair pulling has real evidence behind it, but the evidence is thinner and more modest than the internet suggests. Two small randomized trials in adults found N-acetylcysteine beat placebo for trichotillomania and for skin picking disorder. A trial in children found nothing. Across studies, roughly half of adults who take it see a meaningful change, which also means roughly half do not. It is best understood as a possible add-on to behavioral treatment, not a replacement for it, and it is a conversation to have with a doctor rather than a decision to make from a blog post.
This article is a summary of published research, not medical advice. NAC is sold as a supplement, it interacts with real medical conditions, and what is right for you depends on your health history. Talk to your doctor, psychiatrist, or dermatologist before starting anything, and tell them about every supplement you already take.
What NAC is and why anyone tried it for BFRBs
N-acetylcysteine is a modified form of the amino acid cysteine. In hospitals it has been used for decades as an antidote for acetaminophen overdose and as a mucus thinner. It reached body-focused repetitive behaviors through a different door: the glutamate hypothesis.
The simple version: glutamate is the brain’s main excitatory neurotransmitter, and researchers noticed that circuits involved in compulsive, habit-driven behavior appear to run hot on glutamate. NAC appears to nudge that system back toward balance by influencing how glutamate is exchanged in and out of cells. A 2022 review in Skin Appendage Disorders describes NAC as attenuating glutamatergic hyperactivity, and separately as a precursor to glutathione, the body’s main antioxidant.
That is a mechanism, not a proof. Plausible mechanisms fail in trials all the time. What matters is what happened when people actually took it.
The trials, one at a time
Hair pulling in adults: the 2009 trial
The study that started the interest is Grant, Odlaug, and Kim’s 2009 double-blind trial in Archives of General Psychiatry. Fifty adults with trichotillomania took NAC (1,200 to 2,400 mg per day) or placebo for 12 weeks.
The result was striking for a first trial: 56 percent of the NAC group were rated “much or very much improved” compared with 16 percent on placebo (p = .003), with significant reductions on the Massachusetts General Hospital Hairpulling Scale. Improvement did not separate from placebo until around week nine, which matters if you are the kind of person who gives something three weeks and quits.
Skin picking in adults: the 2016 trial
Seven years later the same group ran a randomized trial in JAMA Psychiatry in 66 adults with excoriation (skin picking) disorder. Dosing started at 1,200 mg per day, rose to 2,400 mg at week three, and reached 3,000 mg at week six, again over 12 weeks.
Severity scores on the Yale-Brown scale modified for skin picking fell from 18.9 to 11.5 on NAC versus 17.9 to 14.1 on placebo (p = .048). At the end, 47 percent on NAC rated themselves much or very much improved, against 19 percent on placebo. Note how close that p-value sits to the .05 threshold. This is a positive result, but a slim one, from a single small study. The authors said so themselves, calling the findings preliminary and asking for larger, longer trials.
Children and teens: the null result
A 2013 add-on trial in the Journal of the American Academy of Child and Adolescent Psychiatry randomized 39 young people aged 8 to 17 with trichotillomania to NAC or placebo for 12 weeks. There was no significant difference on any primary or secondary outcome. Response rates were 25 percent on NAC and 21 percent on placebo, and both groups improved with time regardless of what they were taking.
The authors’ conclusion is worth repeating: assuming that a medication which works in adults will work in children may simply be wrong, and behavioral therapy should be the first-line intervention in young people. If you are a parent reading this for your kid, that null result is the single most relevant finding on this page.
Nail biting: thin evidence
For nail biting, the picture is weakest. The 2022 review describes a pediatric trial of 42 participants in which 800 mg per day produced significantly longer nails after one month, but the effect had faded by month two, plus scattered case reports in adults. That is not enough to build a plan on.
The trials at a glance
| Population | Trial | Result |
|---|---|---|
| Adults, hair pulling | 50 people, 12 weeks | 56% vs 16% much improved |
| Adults, skin picking | 66 people, 12 weeks | 47% vs 19% much improved |
| Ages 8 to 17, hair pulling | 39 people, 12 weeks | No difference vs placebo |
| Children, nail biting | 42 people | Effect at 1 month, gone by 2 |
How big is the effect, honestly
A 2020 systematic review and meta-analysis pooled 24 randomized trials in trichotillomania covering 857 participants. NAC showed a significant effect against placebo (standardized mean difference -0.75) from a single trial, which the authors flagged as needing replication. Behavior therapy built on habit reversal came out at -1.22, the largest effect of anything studied, and the review concluded it has the strongest evidence base for reducing symptoms.
So the honest ranking is: behavioral treatment first, NAC as a possible addition. The TLC Foundation for BFRBs makes the same point in its write-up on NAC, noting that around 44 percent of people in the original trial did not respond and that cognitive behavior therapy should be considered alongside, not instead of, medication.
Realistic expectations look like this: fewer urges, more ability to resist one, longer stretches between episodes. Not a switch that turns the behavior off.
Doses studied, side effects, and cautions
The doses used in trials ranged from about 1,200 to 3,000 mg per day in adults, usually split across the day and increased gradually. That is a description of the research, not a recommendation for you. Dose, timing, and whether NAC is appropriate at all are decisions for a clinician who knows your history, your other medications, and your other diagnoses.
Reported side effects in the skin picking trial were mild, with no serious adverse events: nausea in 14 percent, constipation in 6 percent, dry mouth and dizziness in 3 percent each. The 2022 review lists gastrointestinal symptoms as the common complaint, with headache, rash, and fever noted at higher doses. The TLC Foundation’s article advises that people with asthma avoid NAC. Anyone on blood thinners, anyone pregnant or breastfeeding, and anyone with a chronic condition has an extra reason to ask first.
One more thing worth knowing: dietary supplements are not held to the standard people assume. The NIH Office of Dietary Supplements is blunt that supplements do not require FDA approval before sale and that the FDA does not determine whether they are effective before they are marketed (what you need to know). Product quality varies. The same page advises telling all of your health care providers about any supplement you take, which is good advice even when nothing seems to be going wrong.
Where NAC fits in an actual plan
Think of NAC as something that may lower the volume of the urge. It does not teach you what to do when the urge arrives. That is what behavioral work is for, and it is why the sequence matters more than the supplement.
A reasonable order of operations:
- Learn your pattern. Track when picking or pulling happens, where, and what preceded it. Knowing your mix of automatic and focused behavior changes which tools will help.
- Start behavioral treatment. Habit reversal training is the intervention with the strongest evidence, and it works for skin picking and hair pulling alike.
- Close the awareness gap. Most episodes start before you notice them. Some people use mirrors, bandages, or fidget objects. Hands Down watches for the hand reaching the face or hair and gives a quiet nudge, on-device, which is one way to get the feedback that automatic behavior never provides on its own.
- Then discuss medication or supplements. Bring the trials to the appointment. Ask about your specific health history, what to watch for, and how long to give it before deciding.
Give any trial of NAC a fair length if your doctor agrees to one. The 2009 study did not show separation from placebo until week nine, so judging it at week three tells you very little. Agree in advance on what improvement would look like and when you will reassess, rather than drifting along taking something indefinitely because stopping feels risky.
The short version
NAC is one of the more promising options in a field with no FDA-approved medication for BFRBs, and it is also one of the more oversold. Two small adult trials support it, a pediatric trial does not, the effects are modest, and roughly half of people see no benefit. None of that makes it worthless. It makes it a reasonable thing to ask your doctor about, on top of the behavioral work that carries the strongest evidence, with clear expectations about what a good outcome would actually look like.